Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer (MONAVI-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02591095
Recruitment Status : Completed
First Posted : October 29, 2015
Last Update Posted : March 19, 2019
Sponsor:
Collaborators:
ARCAGY/ GINECO GROUP
French Cancer Research Hospital Program
Information provided by (Responsible Party):
Centre Francois Baclesse

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2017
Actual Study Completion Date : March 2019